Stay updated on GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.

Latest updates to the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page
- Check6 days agoChange DetectedThe page now communicates that recruitment has ended and provides additional guidance sections for readers and potential participants, accompanied by a small heading formatting change and a version update.SummaryDifference0.6%

- Check13 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, reflecting a template or system update for the page. This change does not affect the study details or user-facing information.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe revision tag was updated from v3.5.3 to v3.5.4. This indicates a new release of the page's underlying content/template.SummaryDifference0.1%

- Check42 days agoChange DetectedNo textual changes were reported for the page in the provided data. The study details appear unchanged relative to the prior version.SummaryDifference0.1%

- Check49 days agoChange DetectedNo additions or deletions were provided in the website_changes, so the page content is unchanged. The Study Details and related sections remain as shown on the page.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page updates its platform/build “Revision” from v3.5.2 to v3.5.3, reflecting a site/version change without changing the underlying study details.SummaryDifference0.1%

Stay in the know with updates to GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLP-1 Agonist and Albuminuria in Type 2 Diabetes Clinical Trial page.